BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Long Term Debt 2022–2025
BioXcel Therapeutics, Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- BioXcel Therapeutics, Inc. long term debt as of December 31, 2025: 109.6M, a 6.91% increase year-over-year.
- BioXcel Therapeutics, Inc. long term debt for 2025 were 109.6M, a 6.91% increase from 2024.
- BioXcel Therapeutics, Inc. long term debt for 2024 were 102.5M, a 1.90% increase from 2023.
- BioXcel Therapeutics, Inc. long term debt for 2023 were 100.6M, a 8.11% increase from 2022.
- BioXcel Therapeutics, Inc. long term debt for 2022 were 93.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BioXcel Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $110 |
| 2024 | $103 |
| 2023 | $101 |
| 2022 | $93 |
BioXcel Therapeutics, Inc. Long Term Debt — FAQ
BioXcel Therapeutics, Inc. (BTAI) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's long term debt history?
The chart and table above show BioXcel Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.